Paul W. Maffuid

Paul W. Maffuid

Director Técnico/Científico/I+D en MABVAX THERAPEUTICS HOLDINGS, INC. .

68 años
Health Technology
Consumer Services

Perfil

Paul W.
Maffuid
was the founder of Biopharmalogics, Inc. (founded in 2008) where he served as President from 2008 to 2011.
He is currently working as Executive Vice President-Research & Development at MabVax Therapeutics Holdings, Inc. since 2014.
In his former positions, he worked as Senior Director-Pharmaceutical Development at Amylin Pharmaceuticals, Inc. from 1994 to 1999, Executive Director-Pharmaceutical Development at Magellan Laboratories, Inc. from 1999 to 2001, Vice President-Pharmaceutical Development at Arena Pharmaceuticals, Inc., and Senior Vice President-Operations at Irvine Pharmaceutical Services, Inc. He also briefly served as Executive Vice President at Alcami Carolinas Corp.
in 2011.
Dr. Maffuid holds a doctorate degree from the University of California San Diego.

Cargos activos de Paul W. Maffuid

EmpresasCargoInicio
MABVAX THERAPEUTICS HOLDINGS, INC. Director Técnico/Científico/I+D 08/07/2014
Todos los cargos activos de Paul W. Maffuid

Antiguos cargos conocidos de Paul W. Maffuid.

EmpresasCargoFin
Biopharmalogics, Inc. Fundador 01/01/2011
Corporate Officer/Principal 01/11/2001
Corporate Officer/Principal 01/01/1999
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Paul W. Maffuid.

Formación de Paul W. Maffuid.

University of California San Diego Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Paul W. Maffuid.

Relaciones

28

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Biopharmalogics, Inc.

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA